Abstract B69: Gut microbiome attenuates epithelial ovarian cancer growth and sensitivity to cisplatin: New opportunities for ovarian cancer treatments

医学 卵巢癌 顺铂 内科学 化疗 癌症 微生物群 肿瘤科 抗生素 免疫学 生物信息学 生物 微生物学
作者
Laura Chambers,Emily Esakov,Chad Braley,Leila Edelman,Roberto Vargas,Justin D. Lathia,Chad M. Michener,Ofer Reizes
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:26 (13_Supplement): B69-B69
标识
DOI:10.1158/1557-3265.ovca19-b69
摘要

Abstract Epithelial ovarian cancer (EOC) is the second most common gynecologic malignancy in the United States, but the leading cause of gynecologic cancer death. Despite many women achieving remission with first-line therapy, which includes cytoreductive surgery and platinum-taxane chemotherapy, up to 80% of patients will recur and require additional treatment. The interval from last platinum chemotherapy to recurrence has important prognostic and therapeutic implications for patients. Patients with platinum-resistant EOC have fewer treatment options, worse prognosis, and their disease is seldom curable. Antibiotic therapy is frequently used during cancer treatments in patients with EOC for both prophylaxis and treatment of infections after surgery or through chemotherapy. While critical for the care of the patient, we now appreciate that the microbiome has many roles in maintenance of human health and is increasingly linked with many disease states including obesity, cardiovascular disease, and cancer. Recent evidence suggests the gut microbiome may modulate responses to cancer treatment, including traditional chemotherapy and immunotherapy. Given that antibiotics may lead to microbiome disruption for care of EOC patients and lack of understanding of the impact of these antibiotics on tumor progression, in preclinical models, we assessed the impact of microbiome disruption on EOC progression and cisplatin sensitivity. We established a necessary role for the microbiome in suppression of tumor growth and cisplatin response in two mouse models of EOC. Following treatment with antibiotics (ampicillin, neomycin, vancomycin, and metronidazole), murine ID8 or ID8-VEGF EOC that were injected intraperitoneally into C57Bl/6J mice exhibited accelerated tumor growth compared to non-antibiotic treated controls. Tumor growth was monitored by ultrasound weekly. ID8 and ID8-VEGF tumors in antibiotic-treated mice exhibited reduced sensitivity to cisplatin compared to non-antibiotic controls. Mice treated with antibiotics had significantly worse survival compared to non-antibiotic controls. We confirmed depletion of the gut microbiome based on dilated cecum and reduced microbial 16S rRNA concentration in stool of antibiotic-treated compared to control mice. The accelerated tumor growth and cisplatin resistance was not dependent on an intact immune system as we replicated the effect in immune-deficient mice. In mechanistic studies we determined that disruption of the microbiome led to increased cancer stem cells that was further augmented by cisplatin treatment. Collectively, these studies indicate an intact microbiome provides a tumor-suppressive microenvironment and enhances sensitivity to cisplatin. Future studies will assess whether individual microbial communities are sufficient to reverse the accelerated tumor growth and resistance to cisplatin observed in antibiotic-treated mice and use of selective antibiotics to target pathogenic bacteria while sparing beneficial microbes. Citation Format: Laura Chambers, Emily Esakov, Chad Braley, Leila Edelman, Roberto Vargas, Justin Lathia, Chad Michener, Ofer Reizes. Gut microbiome attenuates epithelial ovarian cancer growth and sensitivity to cisplatin: New opportunities for ovarian cancer treatments [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research; 2019 Sep 13-16, 2019; Atlanta, GA. Philadelphia (PA): AACR; Clin Cancer Res 2020;26(13_Suppl):Abstract nr B69.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
PDIF-CN2完成签到,获得积分10
1秒前
千陽发布了新的文献求助10
1秒前
pipizhu发布了新的文献求助10
1秒前
hungry完成签到,获得积分10
1秒前
3秒前
思源的应助被研友_ndvmV8采纳,获得20
3秒前
000完成签到 ,获得积分10
3秒前
我是老大的应助被eee采纳,获得10
4秒前
Levon发布了新的文献求助10
4秒前
CK组发布了新的文献求助10
4秒前
4秒前
哈哈哈发布了新的文献求助10
4秒前
无奈的煎饼完成签到 ,获得积分10
4秒前
null的应助被科研通管家采纳,获得10
4秒前
4秒前
今后的应助被科研通管家采纳,获得10
4秒前
4秒前
null的应助被科研通管家采纳,获得10
4秒前
奋斗瑶发布了新的文献求助10
4秒前
咯咯哒给咯咯哒的求助进行了留言
4秒前
5秒前
Hello的应助被科研通管家采纳,获得10
5秒前
5秒前
null的应助被科研通管家采纳,获得10
5秒前
5秒前
YOU完成签到,获得积分20
5秒前
星辰大海的应助被科研通管家采纳,获得10
5秒前
英姑的应助被hh采纳,获得10
5秒前
初雪的应助被科研通管家采纳,获得10
5秒前
NexusExplorer的应助被baoziya采纳,获得10
5秒前
5秒前
5秒前
祝新竹完成签到,获得积分10
6秒前
小太阳在营业的应助被OK采纳,获得250
6秒前
完美世界的应助被风趣的扬青采纳,获得10
7秒前
传奇3的应助被负责的代亦采纳,获得10
7秒前
清秀芝麻完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161319
求助须知:如何正确求助?哪些是违规求助? 9556017
关于积分的说明 21731933
捐赠科研通 7751355
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471987